The Seha Virtual Hospital, through its Digital Clinical Research Center, has successfully conducted a pioneering clinical study to verify the accuracy of the AI-powered digital platform iSelfie.ai in the early detection of heart disease and related chronic conditions.

The study included more than 1,000 participants and received approval from the Saudi Food and Drug Authority and the Research and Studies General Department, the Saudi Press Agency reported on Wednesday.

The clinical trial was conducted in collaboration with leading national medical institutions, highlighting the importance of partnerships in advancing medical research in the Kingdom.

The study’s primary goal was to verify the accuracy of the Canadian-developed iSelfie.ai platform, which uses artificial intelligence to analyze facial selfies taken with a standard smartphone camera.

Within seconds, it can measure vital signs such as blood pressure, heart rate, oxygen saturation and respiratory rate.

The study’s results showed that the platform’s accuracy is comparable to traditional medical devices, positioning it as an innovative, rapid and cost-effective solution for early diagnosis.

This technology had previously achieved promising results in clinical trials conducted in the US, Canada and Brazil, the SPA reported.

The Digital Clinical Research Center, launched during the Global Health Exhibition last year, continues to conduct five pioneering digital studies involving artificial intelligence, wearable devices and telemedicine.

This initiative aligns with a strategic direction to accelerate treatment development, enhance research innovation and empower healthcare professionals with advanced tools, ultimately improving quality of life and patient safety in line with health transformation goals and Vision 2030.